Scale-up Systems and ScienView Team Up to Provide Process Development Tools to Chinese Pharma

DUBLIN--Scale-up Systems Ltd., the leading provider of process development software to the pharmaceutical industry, today announced it has entered into a multi-year agreement with ScienView Co. Ltd., a fast-growing Life Science IT products and services company, to provide DynoChem® software, training and process development support services to the Chinese pharmaceutical industry.

The motivation behind the agreement is to provide a dedicated local presence to help Chinese users to obtain maximum value from DynoChem's tools. The initial team in the Beijing and Shanghai offices will be led by Dr. Jinjun Wang for Training & Technical Support and Jack Ma on the Business side.

According to Scale-up Systems CEO Dr. Joe Hannon, "We have been looking for a partner in China that, like our company, specialises in working with and understands the needs of the pharma and life sciences industry. We are therefore delighted to be working with ScienView."

Scale-up Systems COO Dr. Steve Hearn said "What made ScienView stand out to us was the value it placed on hiring high quality training and support staff across multiple domains."

ScienView's Vice President of Informatics Services, Dr. Zhen Wang stated, "Many of our clients are pharmaceutical, chemical or CRO companies, and they are delighted to know that DynoChem will be provided to them along with our top-quality support. With the rapidly increasing R&D investments in China, businesses here also face significant challenges on managing costs and reducing pollution. DynoChem is an excellent tool to help them achieve these goals and is complementary to our products and services."

Jack Ma, Business Development Manager for ScienView, added that "as the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics, ScienView finds that scientists and engineers here are very interested in new techniques and tools that can be applied successfully to their work and can be effectively supported by a local team."

About DynoChem

DynoChem® (www.dynochem.com) is the world's most widely used process design, development and scale-up software for scientists and engineers working in the pharmaceutical industry.

About Scale-up Systems

Scale-up Systems Ltd. (www.scale-up.com) is the owner and developer of DynoChem®. Scale-up Systems supports customers in increasing productivity in R&D and Manufacturing by the adoption of appropriate technologies, enabling collaboration across traditional boundaries and embracing Quality by Design. The company has been operating since 1994 and subsidiaries include its North American distributor, Scale-up Systems Inc., its Indian distributor, Scale-up Systems India Pvt. Ltd and its Asia-Pacific distributor Scale-up Systems (HK) Co., Ltd.

About ScienView

ScienView Co., Ltd. (www.scienview.com) provides scientists in the life science fields with IT services and products, including integration of scientific software and databases, custom software development, data curation service, and cheminformatics and bioinformatics software products. Founded in Beijing in 2006, ScienView has developed a strong team composed of scientists with IT skills and software engineers with scientific knowledge, and most of the team members have either a Master's degree or a PhD. ScienView also has a rapidly expanding team in Shanghai and a field office in San Francisco, USA. ScienView is also the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics.

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.